查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
術中神經監測市場規模、佔有率和成長分析（按產品/服務、來源類型、應用和地區分類）—產業預測（2026-2033 年）
市場調查報告書
商品編碼
1898463

術中神經監測市場規模、佔有率和成長分析（按產品/服務、來源類型、應用和地區分類）—產業預測（2026-2033 年）

Intraoperative Neuromonitoring Market Size, Share, and Growth Analysis, By Product and Services (Systems, Disposables), By Source Type (Insourced Monitoring, Insourced Monitoring), By Application, By Region -Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年，術中神經監測 (IONM) 市場規模將達到 34.3 億美元，到 2025 年將達到 35.9 億美元，到 2033 年將達到 52.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 4.8%。

術中神經監測市場正經歷顯著成長，這主要得益於微創手術需求的不斷成長以及手術病患監測的進步，從而提高了手術安全性並減少了併發症。這一趨勢為改善患者照護和最佳化術後管理提供了重要機會。在手術過程中，尤其是在脊椎手術中，監測肌肉功能健康狀況已成為製造商關注的重點，推動了對術中神經監測（IONM）等監測技術的興趣日益濃厚。此外，專有軟體和術中關節鏡設備的進步正在增強即時決策能力，從而實現更安全、更有效率的手術。該市場的競爭格局涵蓋了領先的醫療設備製造商、專業服務供應商以及遠端監測領域的創新者，他們都在透過夥伴關係和區域擴張來推動技術創新。這使得術中神經監測在全球範圍內更加普及和高效。

術中神經監測市場促進因素

複雜外科手術，尤其是肌肉骨骼手術的增加，顯著地推動了術中神經監測（IONM）市場的發展。隨著人們越來越重視改善術後復健效果和病人安全，這些複雜手術對IONM服務的依賴也日益增強。此外，開發中國家醫療保健系統的進步，加上人口老化和文明病的流行，也促使外科手術數量激增。這些因素共同推動了對IONM的需求，使其成為確保手術成功的關鍵工具。

限制術中神經監測市場的因素

術中神經監測市場成長的主要障礙之一是技術實施和有效操作所需專業技能帶來的沉重經濟負擔。購買一套先進的術中神經監測系統需要大量的初始投資，並且還需要持續的維護和營運成本。此外，提供術中神經監測服務通常需要訓練有素的專業人員，他們憑藉高超的技能和豐富的經驗，獲得極具競爭力的薪資。這些因素共同導致了將術中神經監測整合到外科手術流程中的高成本，阻礙了其廣泛應用。

術中神經監測市場趨勢

術中神經監測市場近年來呈現顯著的發展趨勢，這主要得益於人工智慧 (AI) 和機器學習 (ML) 技術的融合應用。這些技術的進步顯著提升了監測系統的準確性和預測能力，從而能夠快速分析大量資料。透過檢測神經訊號中預示潛在併發症的細微模式，AI 驅動的術中神經監測系統有助於及時做出決策，並最終改善患者預後。此外，監測流程的自動化最大限度地減少了人為干預，並確保了系統在應對營運中斷方面的韌性。隨著醫療保健領域數位化解決方案的日益普及，AI 和 ML 在術中神經監測中的作用將不斷擴大，使其在外科手術環境中發揮更重要的作用。

目錄

介紹

  • 調查目標
  • 定義
  • 市場覆蓋範圍

調查方法

  • 資訊收集
  • 二手和一手資訊來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

    前景
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場動態
    • 促進要素
    • 機會
    • 抑制因素
    • 任務
  • 波特分析

關鍵市場考察

  • 技術分析
  • 定價分析
  • 價值鏈分析
  • 市場生態系統
  • 貿易分析
  • 供應鏈分析
  • 用例分析
  • 專利分析
  • 客戶和購買標準分析
  • 監管環境
  • 創新矩陣
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

術中神經監測市場（依產品/服務分類）

  • 系統
  • 配件
  • 服務

術中神經監測市場依來源類型分類

  • 內部監控
  • 外包監控

按應用分類的術中神經監測市場

  • 脊椎手術
  • 神經外科
  • 整形外科手術
  • 耳鼻喉科手術
  • 血管外科
  • 其他外科手術

按模式分類的術中神經監測市場

  • 運動誘發電位（MEP）
  • 體感誘發電位（SSEPs）
  • 腦電圖（EEG）
  • 肌電圖（EMG）
  • 腦幹聽覺誘發電位（BAEP）
  • 視覺誘發電位（VEP）

按最終用戶分類的術中神經監測市場

  • 醫院
  • 門診手術中心（ASC）

按地區分類的術中神經監測市場規模

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • GCC
    • 南非
    • 其他中東和非洲地區

競爭格局

  • 前五大公司對比
  • 主要企業的市場定位（2025 年）
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市佔率（2025 年）

主要企業簡介

  • 內特斯醫療公司（美國）
  • 精準監測（美國）
  • 神經監測技術（美國）
  • 美敦力（愛爾蘭）
  • NuVasive公司（美國）
  • SpecialtyCare（美國）
  • 卡德威爾工業公司（美國）
  • Alpha Omega Engineering, Inc.（美國）
  • BIoTronic NeuroNetwork（美國）
  • IntraOp Medical Corporation（美國）
  • NeuroWave Systems, Inc.（美國）
  • Integra LifeSciences Corporation（美國）
  • Zynex公司（美國）
  • 美敦力（愛爾蘭）
  • 史賽克公司（美國）
  • 神經監測服務公司（美國）
  • 神經診斷服務（美國）
  • Aesculap公司（美國）
  • Elekta AB（瑞典）
  • OrLive（美國）
  • Stimwave Technologies（美國）
簡介目錄
Product Code: SQMIG35D2016

Intraoperative Neuromonitoring Market size was valued at USD 3.43 Billion in 2024 and is poised to grow from USD 3.59 Billion in 2025 to USD 5.23 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The intraoperative neuromonitoring market is experiencing substantial growth driven by the rising demand for minimally invasive procedures and improved surgical patient monitoring that enhances safety and reduces complications. This trend presents significant opportunities to elevate patient care and optimize postoperative management. Monitoring muscle health during surgical interventions, particularly in spinal procedures, has become a critical factor for manufacturers, fostering increased interest in monitoring technologies like IONM. Additionally, proprietary software and intraoperative arthroscopy devices are enhancing real-time decision-making, resulting in safer and more efficient surgeries. The competitive landscape features medical device giants, specialty service providers, and innovators in remote monitoring, all fostering partnerships and regional expansions to drive continuous technological advancements, ultimately making intraoperative neuromonitoring more accessible and efficient on a global scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Intraoperative Neuromonitoring market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Intraoperative Neuromonitoring Market Segments Analysis

Global Intraoperative Neuromonitoring Market is segmented by Products and Services, Source Type, Application, Modality, End User, and region. Based on Products and Services, the market is segmented into Systems, Accessories, and Services. Based on Source Type, the market is segmented into Insourced Monitoring, and Outsourced Monitoring. Based on Application, the market is segmented into Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, and Other surgeries. Based on Modality, the market is segmented into Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG),Electromyography(EMG), Brainstem auditory evoked potentials (BAEPs), and Visual evoked potentials (VEPs). Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Intraoperative Neuromonitoring Market

The rise in complex surgical procedures, particularly in the field of musculoskeletal surgeries, is significantly propelling the Intraoperative Neuromonitoring (IONM) market. There is a growing emphasis on enhancing recovery outcomes and patient safety, which has spurred an increased reliance on IONM services during these intricate operations. Additionally, advancements in healthcare systems within developing countries are contributing to a surge in surgical interventions, driven by an aging population and the prevalence of lifestyle-related health issues. This convergence of factors is creating a heightened demand for IONM as a vital tool in ensuring successful surgical results.

Restraints in the Intraoperative Neuromonitoring Market

One of the primary obstacles hindering the growth of the intraoperative neuromonitoring (IONM) market is the significant financial burden linked to both the technology and the specialized knowledge necessary for effective implementation. The initial investment needed to procure advanced IONM systems can be substantial, alongside continuous expenses for maintenance and operation. Additionally, the provision of IONM services typically requires highly trained professionals, whose expertise commands competitive salaries due to the skill level and proficiency involved. These factors collectively contribute to the high costs associated with integrating IONM into surgical practices, posing a barrier to widespread adoption.

Market Trends of the Intraoperative Neuromonitoring Market

The Intraoperative Neuromonitoring (IONM) market is witnessing a significant trend driven by the integration of Artificial Intelligence (AI) and Machine Learning (ML) technologies. These advancements are enhancing the accuracy and predictive capabilities of monitoring systems, allowing for rapid analysis of extensive datasets. By detecting subtle patterns in neural signals indicative of potential complications, AI-powered IONM systems facilitate timely decision-making and improve patient outcomes. Moreover, the automation of monitoring processes minimizes the need for extensive human intervention, ensuring resilience against operational disruptions. As the healthcare sector increasingly adopts digital solutions, the role of AI and ML in IONM will continue to expand, reinforcing their importance in surgical settings.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Trade Analysis
  • Supply chain Analysis
  • Case study Analysis
  • Patent Analysis
  • Customer & Buying Criteria Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Intraoperative Neuromonitoring Market by Products and Services

  • Market Overview
  • Systems
  • Accessories
  • Services

Intraoperative Neuromonitoring Market by Source Type

  • Market Overview
  • Insourced Monitoring
  • Outsourced Monitoring

Intraoperative Neuromonitoring Market by Application

  • Market Overview
  • Spinal Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • ENT Surgery
  • Vascular Surgery
  • Other surgeries

Intraoperative Neuromonitoring Market by Modality

  • Market Overview
  • Motor evoked potentials (MEPs)
  • Somatosensory evoked potentials (SSEPs)
  • Electroencephalography (EEG)
  • Electromyography (EMG)
  • Brainstem auditory evoked potentials (BAEPs)
  • Visual evoked potentials (VEPs)

Intraoperative Neuromonitoring Market by End User

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

Intraoperative Neuromonitoring Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • Natus Medical Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accurate Monitoring (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neuromonitoring Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NuVasive, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SpecialtyCare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cadwell Industries, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alpha Omega Engineering, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronic NeuroNetwork (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IntraOp Medical Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NeuroWave Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nerve Monitoring Services, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurodiagnostic Services (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aesculap, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OrLive (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stimwave Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments